Comparing two antibiotics for pneumonia in hospital
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial compares azithromycin and doxycycline for adults hospitalized with community-acquired pneumonia who are already getting a beta-lactam antibiotic. It aims to see which works better as an add-on treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You are admitted to the hospital for community-acquired pneumonia
- You received a beta-lactam antibiotic (like ceftriaxone) plus either azithromycin or doxycycline in the emergency room within 12 hours of being admitted
- You do not have a strong suspicion of Legionella pneumonia
- You are not allergic to azithromycin or doxycycline
- You are not pregnant
- Your pneumonia is not severe (based on specific medical criteria)
- You do not have a prolonged QT interval on your heart monitor
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares how long antibiotics should be given to people hospitalized with moderately severe community-acquired pneumonia. It uses your early improvement to see which antibiotic duration works best and safely.
This trial compares different antibiotic strategies for children with pneumonia who are being treated as outpatients. The goal is to find the best approach to treat the infection and help your child recover.
This trial is testing how many days of antibiotics are best for adults with pneumonia who are treated by their regular doctor (not in a hospital). The goal is to find the shortest effective treatment to reduce side effects and antibiotic resistance.
This trial compares two antibiotics for older adults hospitalized with pneumonia. It aims to see if amoxicillin alone works as well as amoxicillin combined with clavulanate, which might reduce side effects.
This study tests whether the antibiotic clarithromycin can prevent pneumonia from getting worse and turning into sepsis. It is for adults with community-acquired pneumonia who have certain signs of infection in their blood.
This study compares two antibiotics, doxycycline and a macrolide, to see which works better for children with pneumonia caused by a bacteria called Mycoplasma pneumoniae, especially when the bacteria might be resistant to the usual treatment.
Hear when a new Community-acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.